Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,768,983
+$1,397,994 QoQ
Shares Held
73,789
+47.3% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OMERS ADMINISTRATION Corp holds $60,860,531 across 83 Biotechnology names. HALO ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
18,797 | $8,393,612 | |
| 2 | TECH |
BIO-TECHNE Corp
|
141,443 | $7,391,811 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,179 | $6,319,422 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
73,789 | $4,768,983 | |
| 5 | INCY |
Incyte Corp
|
41,083 | $3,866,731 | |
| 6 | RPRX |
Royalty Pharma plc
|
79,307 | $3,804,356 | |
| 7 | EXEL |
Exelixis, Inc.
|
88,362 | $3,789,846 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
8,092 | $1,529,792 |
All Filings in HALO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,768,983 | 73,789 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,370,989 | 50,089 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,085,432 | 14,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $769,896 | 14,800 | Shares | Sole | 2025-08-13 | |
| 2024-06-30 | $324,632 | 6,200 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||